H Gelband
Overview
Explore the profile of H Gelband including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
698
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Visser A, Moore D, Whitelaw A, Lowman W, Kantor G, Hoosen A, et al.
S Afr Med J
. 2011 Sep;
101(8 Pt 2):587-95.
PMID: 21920138
No abstract available.
2.
Bamford C, Brink A, Govender N, Lewis D, Perovic O, Botha M, et al.
S Afr Med J
. 2011 Sep;
101(8 Pt 2):579-82.
PMID: 21920136
No abstract available.
3.
Winters C, Gelband H
S Afr Med J
. 2011 Sep;
101(8 Pt 2):556-7.
PMID: 21920132
No abstract available.
4.
Graves P, Gelband H
Cochrane Database Syst Rev
. 2007 Jul;
(4):CD000129.
PMID: 17636596
Background: Four types of malaria vaccine, SPf66 and MSP/RESA vaccines (against the asexual stages of the Plasmodium parasite) and CS-NANP and RTS,S vaccines (against the sporozoite stages), have been tested...
5.
Adinarayanan S, Critchley J, Das P, Gelband H
Cochrane Database Syst Rev
. 2007 Jan;
(1):CD003758.
PMID: 17253495
Background: Mass treatment with diethylcarbamazine (DEC)-medicated salt has been used in a number of places as a control measure for lymphatic filariasis. We sought reliable evidence about its effect on...
6.
Graves P, Gelband H
Cochrane Database Syst Rev
. 2006 Oct;
(4):CD006199.
PMID: 17054281
Background: A malaria vaccine is needed because of the heavy burden of mortality and morbidity due to this disease. This review describes the results of trials of blood (asexual)-stage vaccines....
7.
Graves P, Gelband H
Cochrane Database Syst Rev
. 2006 Oct;
(4):CD006198.
PMID: 17054280
Background: Vaccines against all stages of the malaria parasite are in development, mainly for Plasmodium falciparum, which causes the most serious form of malaria. Pre-erythrocytic vaccines act to prevent or...
8.
Graves P, Gelband H, Garner P
Parasitol Today
. 2006 Oct;
14(6):218-20.
PMID: 17040762
No abstract available.
9.
Graves P, Gelband H
Cochrane Database Syst Rev
. 2006 Apr;
(2):CD005966.
PMID: 16625647
Background: A malaria vaccine is badly needed. SPf66 was one of the earliest vaccines developed. It is a synthetic peptide vaccine containing antigens from the blood stages of malaria linked...
10.
Critchley J, Addiss D, Gamble C, Garner P, Gelband H, Ejere H
Cochrane Database Syst Rev
. 2005 Oct;
(4):CD003753.
PMID: 16235339
Background: Mass treatment with albendazole co-administered with another antifilarial drug is part of a global programme to eliminate lymphatic filariasis. We sought reliable evidence of the effects of albendazole on...